Résistance aux antiplaquettaires : mythe ou réalité ?

Rucker, 2019, Physiology, Thromboxane A2. StatPearls, Treasure Island (FL) Schomig, 2009, Ticagrelor--is there need for a new player in the antiplatelet-therapy field?, N Engl J Med, 361, 1108, 10.1056/NEJMe0906549 Cattaneo, 2010, New P2Y(12) inhibitors, Circulation, 121, 171, 10.1161/CIRCULATIONAHA.109.853069 Cattaneo, 2004, Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance, Arterioscler Thromb Vasc Biol, 24, 1980, 10.1161/01.ATV.0000145980.39477.a9 Frelinger, 2006, Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance, Circulation, 113, 2888, 10.1161/CIRCULATIONAHA.105.596627 Santos, 2017, The time between venepuncture and blood incubation is critical for serum thromboxane B2 synthesis, Platelets, 28, 310, 10.1080/09537104.2016.1246719 Hayward, 2010, Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry, Am J Clin Pathol, 134, 955, 10.1309/AJCP9V3RRVNZMKDS Homorodi, 2016, The lack of aspirin resistance in patients with coronary artery disease, J Transl Med, 1474 Huang, 2019, Antiplatelet Therapy Monitoring in Neonates and Children, Semin Thromb Hemost, 45, 73, 10.1055/s-0038-1676375 Brar, 2011, Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data, J Am Coll Cardiol, 58, 1945, 10.1016/j.jacc.2011.06.059 Cattaneo, 2012, Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution?, J Thromb Haemost, 10, 327, 10.1111/j.1538-7836.2011.04602.x Le Quellec, 2016, Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response. A review of the literature, Thromb Haemost, 116, 638 Bagoly, 2013, Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy, PLoS One, 8, e69417, 10.1371/journal.pone.0069417 Bagoly, 2016, How to test the effect of aspirin and clopidogrel in patients on dual antiplatelet therapy?, Platelets, 27, 59, 10.3109/09537104.2015.1031098 Danese, 2016, Relationship between pharmacokinetics and pharmacodynamics of clopidogrel in patients undergoing percutaneous coronary intervention: comparison between vasodilator-stimulated phosphoprotein phosphorylation assay and multiple electrode aggregometry, J Thromb Haemost, 14, 282, 10.1111/jth.13197 Cattaneo, 2007, Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection, J Thromb Haemost, 5, 1230 Price, 2011, Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial, 305, 1097 Collet, 2012, Bedside monitoring to adjust antiplatelet therapy for coronary stenting, N Engl J Med, 367, 2100, 10.1056/NEJMoa1209979 Siller-Matula, 2013, Why have studies of tailored anti-platelet therapy failed so far?, Thromb Haemost, 110, 628 Parodi, 2011, High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI, JAMA, 306, 1215, 10.1001/jama.2011.1332 Podda, 2017, Prediction of high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndromes, Int J Cardiol, 24060 Valgimigli, 2018, 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS, Eur J Cardiothorac Surg, 53, 34, 10.1093/ejcts/ezx334 Kaikita, 2019, Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease, Thromb Haemost